Using plasma amyloid oligomer to screen Alzheimer's disease

Abstract

Background: Previous studies have shown that plasma amyloid‐beta oligomers(AβO), the toxic form of Aβ found in the blood, as a critical issue to develop or worsen Alzheimer's disease (AD). We have examined plasma amyloid‐beta oligomers and their related biomarkers in a case‐control study to clarify these issues.

The paper